RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

216 hedge funds and large institutions have $2.46B invested in Revance Therapeutics, Inc. in 2023 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 63 increasing their positions, 74 reducing their positions, and 25 closing their positions.

Holders
216
Holders Change
+23
Holders Change %
+11.92%
% of All Funds
3.46%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
50
Increased
63
Reduced
74
Closed
25
Calls
$57.2M
Puts
$22.6M
Net Calls
+$34.5M
Net Calls Change
-$63.9M
Name Market Value Shares Shares
Change
Shares
Change %
BBP
226
Banco BTG Pactual
Brazil
-24,200 Closed
HSBC Holdings
227
HSBC Holdings
United Kingdom
-19,000 Closed
Capital Fund Management (CFM)
228
Capital Fund Management (CFM)
France
-16,900 Closed
GT
229
Glenmede Trust
Pennsylvania
-15,774 Closed
NC
230
NinePointTwo Capital
California
-11,774 Closed
LOAMU
231
Lombard Odier Asset Management (USA)
New York
-11,177 Closed
PMEF
232
Point72 Middle East FZE
United Arab Emirates
-8,048 Closed
CG
233
Cutler Group
California
-4,760 Closed
PGAM
234
Princeton Global Asset Management
New Jersey
-2,500 Closed
MCC
235
Money Concepts Capital
Florida
-2,150 Closed
CAL
236
Capital Advisors Ltd
Ohio
-760 Closed
USCWA
237
U.S. Capital Wealth Advisors
Texas
-250 Closed
Rockefeller Capital Management
238
Rockefeller Capital Management
New York
-100 Closed
FFA
239
Fairfield Financial Advisors
Massachusetts
-80 Closed
SIC
240
SJS Investment Consulting
Ohio
-2 Closed
Point72 Asset Management
241
Point72 Asset Management
Connecticut
CFGS
242
Concourse Financial Group Securities
Alabama
JGC
243
J. Goldman & Co
New York
TLP
244
Tri Locum Partners
New York
C
245
Covestor
United Kingdom
$0 8
AC
246
Antara Capital
New York
HT
247
HAP Trading
New York
Toronto Dominion Bank
248
Toronto Dominion Bank
Ontario, Canada
$0 5 +5 New